Marvel Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 2, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022	Jul '21 Jul 31, 2021
Market Capitalization	8	9	5	3	3	8
Market Cap Growth	12.76%	72.43%	68.85%	0.97%	-59.69%	-
Enterprise Value	10	11	7	3	3	8
Last Close Price	0.14	0.17	0.12	0.08	0.09	0.24
PB Ratio	-2.14	-2.31	-1.90	-1.85	16.12	3.32
P/TBV Ratio	-	-	-	-	16.12	3.32
Debt / Equity Ratio	-0.63	-0.58	-0.60	-0.58	-	-
Net Debt / Equity Ratio	-0.46	-0.54	-0.48	-0.26	-3.03	-1.02
Net Debt / EBITDA Ratio	-	-	-	-0.20	0.24	1.92
Net Debt / FCF Ratio	-1.57	-1.90	-1.16	-0.33	0.27	1.75
Quick Ratio	0.15	0.07	0.14	0.46	0.91	21.80
Current Ratio	0.16	0.08	0.15	0.48	1.27	21.94
Return on Equity (ROE)	-	-	-	-	-200.23%	-245.66%
Return on Assets (ROA)	-208.42%	-227.66%	-131.54%	-172.83%	-92.62%	-56.48%
Return on Capital Employed (ROCE)	41.60%	37.20%	43.30%	304.50%	-1281.50%	-53.00%
Earnings Yield	-29.06%	-23.86%	-30.70%	-71.99%	-81.02%	-38.86%
FCF Yield	-	-12.41%	-21.95%	-41.86%	-69.60%	-17.52%
Buyback Yield / Dilution	-21.32%	-18.37%	-0.77%	-21.07%	-85.11%	-140.11%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.